Hengrui Medicine (01276.HK) spent 33.736 million yuan on August 3 to repurchase 637,000 A-shares.

Zhuhua Finance APP news, Hongrui Pharmaceutical (01276.HK) announced that the company will spend 33.736 million RMB to repurchase 637,000 A-shares on August 3, 2026, with a repurchase price of 52.87-53.08 RMB per share.